The ruling is a blow to the government effort to force down drug prices and consumer health costs.

The deal will give AbbVie a set of products big enough to diversify its revenue from Humira, the top-selling rheumatoid arthritis injection.

The lawsuit asserts that HHS doesn't have the legal power to compel drugmakers to include prices in their ads.

UnitedHealth fell 3 percent at 10:30 a.m. in New York. Its competitor Anthem was down 4.8 percent, and Cigna slid 3.1 percent.

The insurer, which covers almost 50 million people, said the proposals amount to a “wholesale disruption of American health care.”

Bankruptcy would let the company negotiate claims with some of the more than 1,500 entities that have sued Purdue over its role in the opioid epidemic.

The new governor wants to shift the state's Medicaid program to a direct purchase system and allow private businesses to join its buying pool.

The companies have held discussions about a variety of joint ventures, including expanding their partnership serving older people.